OverweightNCT06677073
Effects of FATmax Exercise and HIIT on Fat Loss in Overweight Young Women
A study testing High-intensity interval training and Maximal fat oxidation exercise in people with Overweight, run by Beijing Sport University at 1 site in China.
Trial summary
This study investigated the effects of two exercise modalities: high-intensity interval training (HIIT) and maximal fat oxidation (FATmax) exercise on fat loss in overweight young women. Participants were randomly assigned to either the HIIT or FATmax group, underwent an 8-week supervised exercise intervention. Read more about this study
- Who is it for?
- Ages 18 to 30 years, women onlyHealthy volunteers can take part
- Conditions the study is for
- Overweight
- What is being tested?
- High-intensity interval training and Maximal fat oxidation exercise
- Type of treatment
- Lifestyle or therapy programme
- Could I receive a placebo?
- No, everyone receives an active treatment
- How many people
- 20 participants
- Where
- 1 siteChina
- Study dates
- 15 Apr 2021to 30 Dec 2021
- Phase
- Interventional
- Are there results?
- None posted in the registry
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages 18 to 30 years
- Women only
- Healthy volunteers accepted
- Adult
Who may be able to join
- Female, aged between 18 and 30 years.
- Overweight, BMI greater than 24.0 kg·m-2.
- Participants Lack of exercise habits.
- Participants Without significant fluctuation in weight.
Who cannot join
- Participants took drugs affecting metabolism and hormones during the experimental period.
- Participants had a history of oral weight loss pills and contraceptive pills.
- Participants had a history of smoking, alcohol consumption, or daily consumption of caffeine-containing beverages.
- Participants had cardiovascular or basal metabolic disorders, such as hypertension, coronary heart disease, or diabetes mellitus.
- Participants had other acute or chronic injuries related to exercise.
Trial locations and contacts
1 site in 1 country.
China1 site
School of Sports Medicine and Rehabilitation, Beijing Sport University
Beijing
About this study
Official title: Effects of Maximal Fat Oxidation Exercise and High-intensity Interval Training on Fat Loss in Overweight Young Women
This study investigated the effects of two exercise modalities: high-intensity interval training (HIIT) and maximal fat oxidation (FATmax) exercise on fat loss in overweight young women. Participants were randomly assigned to either the HIIT or FATmax group, underwent an 8-week supervised exercise intervention.
Read the detailed description
This study aims to compare the effects of HIIT and FATmax exercise on fat loss in overweight young women. Participants were recruited and randomly assigned to either the HIIT group or the FATmax group. The intervention lasted for 8 weeks, during which participants maintained their usual diet. Both body morphology and body composition were assessed before and after the intervention. In order to recommend exercise strategy for overweight young women reduce fat and improve their health.
- Conditions
- Overweight
- Being tested
- High-intensity interval training, Maximal fat oxidation exercise
- Keywords
- High-intensity interval training, Maximal fat oxidation, Overweight, Fat loss, Female
- Medical subject headings
- Overweight
What participants receive
What participants receive. In a randomised study each person is assigned to one group by chance.
High-intensity interval trainingBehavioural
High-intensity interval training
Maximal fat oxidation exerciseBehavioural
Maximal fat oxidation exercise
| Study group | Role | What they receive |
|---|---|---|
| HIIT group | Experimental | Not described Receives: Behavioral: High-intensity interval training |
| FATmax group | Experimental | Not described Receives: Behavioral: Maximal fat oxidation exercise |
What is being measured
The primary outcome is the main question the study is designed to answer.
Body weight
The change of body weight before and after intervention.
Measured: 8 weeks
Body mass index (BMI)
The change of body mass index before and after intervention.
Measured: 8 weeks
Waist circumference
The change of waist circumference before and after intervention.
Measured: 8 weeks
Hip circumference
The change of hip circumference before and after intervention.
Measured: 8 weeks
Body fat weight
The change of body fat weight before and after intervention.
Measured: 8 weeks
Body fat percentage
The change of body fat percentage before and after intervention.
Measured: 8 weeks
Visceral fat area
The change of visceral fat area before and after intervention.
Measured: 8 weeks
Secondary outcomes (1)
Height
The change of height before and after intervention.
Measured: 8 weeks
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted6 Nov 2024
- Study start15 Apr 2021
- Primary completion30 Sep 2021
- Study completion30 Dec 2021
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Other trials for OverweightStudies of the same condition, open and under way.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Interventional
- Phase
- Phase N/A
- Primary purpose
- Prevention
- Allocation
- Randomised
- Intervention model
- Parallel groups
- Masking
- Single blind
- Who is masked
- Outcomes assessor
- Enrolment
- 20 participants (actual)
Sponsor and investigators
- Lead sponsor
- Beijing Sport University
- Sponsor type
- University, hospital or other
- Responsible party
- Sponsor
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT06677073
- Sponsor's protocol ID
- EOMFOEAHITOFLIOYW
- Status last verified
- Nov 2024
- First submitted
- 5 Nov 2024
- Last updated
- 6 Nov 2024
- Results posted
- No
- Data monitoring committee
- No
- FDA-regulated drug
- No
- FDA-regulated device
- No
- Individual data sharing
- No
Study at a glance
From the registry record, last updated by the sponsor on 6 Nov 2024. Recruitment status is as the sponsor reported it: confirm with the study team.
- Official title
- Effects of Maximal Fat Oxidation Exercise and High-intensity Interval Training on Fat Loss in Overweight Young Women
- ClinicalTrials.gov ID
- NCT06677073
- Acronym / sponsor ID
- EOMFOEAHITOFLIOYW
- Conditions
- Overweight
- Keywords
- High-intensity interval training, Maximal fat oxidation, Overweight, Fat loss, Female
- Study type
- Interventional
- Recruitment status
- Completed
- Enrolment
- 20 participants (actual)
- Lead sponsor
- Beijing Sport UniversityUniversity, hospital or other
- Study start
- 15 Apr 2021 (actual)
- Primary completion
- 30 Sep 2021 (actual)
- Study completion
- 30 Dec 2021 (actual)
- First posted
- 6 Nov 2024 (actual)
- Results
- Not posted in the source record
Clinical summary
The research question as the sponsor registered it. This describes what the study plans to test, not what it found.
This study investigated the effects of two exercise modalities: high-intensity interval training (HIIT) and maximal fat oxidation (FATmax) exercise on fat loss in overweight young women. Participants were randomly assigned to either the HIIT or FATmax group, underwent an 8-week supervised exercise intervention.
Detailed description
This study aims to compare the effects of HIIT and FATmax exercise on fat loss in overweight young women. Participants were recruited and randomly assigned to either the HIIT group or the FATmax group. The intervention lasted for 8 weeks, during which participants maintained their usual diet. Both body morphology and body composition were assessed before and after the intervention. In order to recommend exercise strategy for overweight young women reduce fat and improve their health.
Study design
- Primary purpose
- Prevention
- Allocation
- Randomised
- Intervention model
- Parallel groups
- Masking
- Single blind (outcomes assessor)
- Number of arms
- 2
| Arm | Type | Receives |
|---|---|---|
| HIIT group | Experimental | Behavioral: High-intensity interval training |
| FATmax group | Experimental | Behavioral: Maximal fat oxidation exercise |
Who may qualify
- Ages
- 18 to 30 years
- Sex
- Female only
- Healthy volunteers
- Accepted
- Age groups
- Adult
Key inclusion criteria (4 listed)
- Female, aged between 18 and 30 years.
- Overweight, BMI greater than 24.0 kg·m-2.
- Participants Lack of exercise habits.
- Participants Without significant fluctuation in weight.
Key exclusion criteria (5 listed)
- Participants took drugs affecting metabolism and hormones during the experimental period.
- Participants had a history of oral weight loss pills and contraceptive pills.
- Participants had a history of smoking, alcohol consumption, or daily consumption of caffeine-containing beverages.
- Participants had cardiovascular or basal metabolic disorders, such as hypertension, coronary heart disease, or diabetes mellitus.
- Participants had other acute or chronic injuries related to exercise.
Eligibility is decided by the study team after screening; this overview does not establish that a patient qualifies. Full inclusion and exclusion criteria.
Interventions
| Intervention | Type | Arms |
|---|---|---|
| High-intensity interval trainingHigh-intensity interval training | Behavioural | HIIT group |
| Maximal fat oxidation exerciseMaximal fat oxidation exercise | Behavioural | FATmax group |
Primary outcome
Body weight
Time frame: 8 weeks
The change of body weight before and after intervention.
Body mass index (BMI)
Time frame: 8 weeks
The change of body mass index before and after intervention.
Waist circumference
Time frame: 8 weeks
The change of waist circumference before and after intervention.
Hip circumference
Time frame: 8 weeks
The change of hip circumference before and after intervention.
Body fat weight
Time frame: 8 weeks
The change of body fat weight before and after intervention.
Body fat percentage
Time frame: 8 weeks
The change of body fat percentage before and after intervention.
Visceral fat area
Time frame: 8 weeks
The change of visceral fat area before and after intervention.
1 secondary outcome
Height
Time frame: 8 weeks
Results and safety
The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.
Research links
- Official record on ClinicalTrials.govLast updated by the sponsor 6 Nov 2024.
- Individual participant dataSharing planned: No
Related trials for Overweight
RecruitingObservational study
Endoscopic Sleeve Gastroplasty (ESG) Prospective Trial for Obesity (EGO-Trial)
Obesity
Active, not recruitingPhase 4
Effects of Sequential Therapy With Mexidol® (Intravenous) and Mexidol® FORTE 250 (Oral) on Functional Brain Activity Assessed by Functional Magnetic Resonance Imaging and Biochemical Parameters in Patients With Chronic Cerebral Ischemia: A Comparison of Patients With and Without Metabolic Disorders
Metabolic Abnormalities, Obesity & Overweight
Recruiting
Exercise Training and Vitamin D Metabolism
Obesity & Overweight, Vitamin D
Recruiting
Metabolic Health, Bones and Nuts During Weight Loss in Adults
Weight Loss, Bone Density
Active, not recruiting
Effect of Probiotics on Insulin Sensitivity in Overweight and Obese Pregnancy
Obesity & Overweight, Gestational Diabetes Mellitus (GDM)
Referral and contact
AzTrials does not enrol participants or take referrals. Contact the study team or a site listed below; they decide who can take part. This study is not recruiting at the moment.
The record lists no contact. Use the official record to reach the sponsor.
1 site in 1 country: see every site and its status.
Questions about this trial
What is this clinical trial studying?
A study testing High-intensity interval training and Maximal fat oxidation exercise in people with Overweight, run by Beijing Sport University at 1 site in China.
The full registered description is in the About this study section and the official record.
Who may be eligible to take part?
The sponsor lists 4 inclusion and 5 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.
Is this clinical trial currently recruiting?
The record says: finished, as of the sponsor's last update on 6 Nov 2024. Status can change between updates, so confirm with the study contact before making plans.
Where is the study taking place?
The record lists 1 site in China. Whether a site is taking part right now should be confirmed with that site. See every site.
What are the possible benefits and risks?
They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.
Are results available for this study?
The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.
How can a doctor refer a patient or contact the research team?
The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.
What does the primary outcome measure?
Body weight (time frame: 8 weeks). The study lists 7 primary outcomes in all. It is what the study was designed to measure, not a finding.
Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?
No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.
How often is this information updated?
AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 6 Nov 2024.